 |
|
|
|
|
 |
Last Updated: Sep 8, 2007 - 1:21:03 PM |
Latest Research
Genetic mutations identified for type of gastric cancer
Researchers have identified novel genetic mutations that are linked to hereditary diffuse gastric cancer, with these mutations being due to both independent mutational events and common ancestry, according to a study in the June 6 issue of JAMA. This study is being released early to coincide with its presentation at the annual meeting of the American Society of Clinical Oncology.
Jun 5, 2007 - 4:00:00 AM
|
Latest Research
:
Cancer
:
Gastric Cancer
Less than one third gastric cancer patients actually have adequate lymph node assessments
Most patients who undergo gastric cancer staging by lymph node sampling have inadequate assessments that compromise survival, according to a new study. Published in the November 1, 2006 issue of CANCER , a peer-reviewed journal of the American Cancer Society, the study reveals that less than one third of gastric cancer patients had adequate lymph node assessments (ALNA).
Sep 25, 2006 - 6:38:00 PM
|
Latest Research
:
Cancer
:
Gastric Cancer
Long term benefits of Imatinib in advanced gastrointestinal stromal tumors (GIST) confirmed
People with advanced gastrointestinal stromal tumors (GIST) who take Gleevec (imatinib) for prolonged periods continue to benefit from the drug, according to a five-year study by Oregon Health & Science University Cancer Institute researchers.
Jun 5, 2006 - 4:37:00 PM
|
Latest Research
:
Cancer
:
Gastric Cancer
New discoveries to tackle stomach cancer
A research team has come up with a molecular map and other discoveries to help develop better treatment for stomach cancer, which is common in Asians, researchers said Friday.
Mar 3, 2006 - 12:55:00 PM
|
Latest Research
:
Cancer
:
Gastric Cancer
Stomach cancer formation can be supressed by by lowering Stat3 hyperactivity
It started several years ago with the observation that a large group of seemingly unconnected genes were behaving differently in patients with stomach cancer. Now a multi-national research team led by the Melbourne Branch of the Ludwig Institute for Cancer Research (LICR) has joined the proverbial dots and identified a potential new target for stomach cancer therapy, according to a paper published today in the prestigious Nature Medicine journal.
Jul 25, 2005 - 5:30:00 PM
|
<< prev
next >>
|
|
|
|
